AASLD/ILTS transplant course: Is there an extended donor suitable for everyone?

被引:39
作者
Cameron, A [1 ]
Busuttil, RW [1 ]
机构
[1] Univ Calif Los Angeles, Dumont Transplant Ctr, Ctr Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1002/lt.20596
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Key Points 1. The clinical success of liver transplantation coupled with the current era of organ shortage has caused many centers to expand their criteria for acceptable donors. 2. The definition of "Extended Criteria Donor" (ECD) is becoming better understood and quantified. 3. Recipient factors that portend poor outcome must be recognized and factored in as well. Grafts and recipients must be "matched" to manage and minimize the risk from ECDs. 4. Maintaining acceptable outcomes as ECD concepts evolve is paramount. 5. Absolute risk factors for poor graft function still exist and must be respected, but relative risk factors are now well identified, quantified, accepted, and managed as an alternative to high waiting list mortality. (Liver Transpl 2005.)
引用
收藏
页码:S2 / S5
页数:4
相关论文
共 12 条
[1]   Survival following liver transplantation from non-heart-beating donors [J].
Abt, PL ;
Desai, NM ;
Crawford, MD ;
Forman, LM ;
Markmann, JW ;
Olthoff, KM ;
Markmann, JF .
ANNALS OF SURGERY, 2004, 239 (01) :87-92
[2]   Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].
Berenguer, M ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Martinez, F ;
Carrasco, D ;
Moya, A ;
Orbis, F ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2002, 36 (01) :202-210
[3]   The utility of marginal donors in liver transplantation [J].
Busuttil, RW ;
Tanaka, K .
LIVER TRANSPLANTATION, 2003, 9 (07) :651-663
[4]   Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors [J].
Dodson, SF ;
Bonham, CA ;
Geller, DA ;
Cacciarelli, TV ;
Rakela, J ;
Fung, JJ .
TRANSPLANTATION, 1999, 68 (07) :1058-1061
[5]   A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients [J].
Ghobrial, RM ;
Steadman, R ;
Gornbein, J ;
Lassman, C ;
Holt, CD ;
Chen, P ;
Farmer, DG ;
Yersiz, H ;
Danino, N ;
Collisson, E ;
Baquarizo, A ;
Han, SS ;
Saab, S ;
Goldstein, LI ;
Donovan, JA ;
Esrason, K ;
Busuttil, RW .
ANNALS OF SURGERY, 2001, 234 (03) :384-393
[6]   Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers [J].
Marroquin, CE ;
Marino, G ;
Kuo, PC ;
Plotkin, JS ;
Rustgi, VK ;
Lu, AD ;
Edwards, E ;
Taranto, S ;
Johnson, LB .
LIVER TRANSPLANTATION, 2001, 7 (09) :762-768
[7]   Implication of advanced donor age on the outcome of liver transplantation [J].
Oh, CK ;
Sanfey, HA ;
Pelletier, SJ ;
Sawyer, RG ;
McCullough, CS ;
Pruett, TL .
CLINICAL TRANSPLANTATION, 2000, 14 (04) :386-390
[8]   Role of gender and race mismatch and graft failure in patients undergoing liver transplantation [J].
Rustgi, VK ;
Marino, G ;
Halpern, MT ;
Johnson, LB ;
Umana, WO ;
Tolleris, C .
LIVER TRANSPLANTATION, 2002, 8 (06) :514-518
[9]   Long-term outcome of patients transplanted with livers from hepatitis C-positive donors [J].
Testa, G ;
Goldstein, RM ;
Netto, G ;
Abbasoglu, O ;
Brooks, BK ;
Levy, MF ;
Husberg, BS ;
Gonwa, TA ;
Klintmalm, GB .
TRANSPLANTATION, 1998, 65 (07) :925-929
[10]   Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effect of correction of donor hypernatremia [J].
Totsuka, E ;
Dodson, F ;
Urakami, A ;
Moras, N ;
Ishii, T ;
Lee, MC ;
Gutierrez, J ;
Gerardo, M ;
Molmenti, E ;
Fung, JJ .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (05) :421-428